Quoin Pharmaceuticals LT-ADRQNRX
13F holders, Q4 2025 (December 31)18holders +14
14new positions
0sold out
1famous investor
$14.43avg. 13F price*
At the end of Q4 2025, 18 institutions reported holding Quoin Pharmaceuticals LT-ADR (QNRX) in their 13F filings, up 14 from Q3 2025. 14 opened new positions and 0 sold out. The largest holders were Ikarian Capital, LLC ($3.1M), Woodline Partners LP ($1.1M) and Stonepine Capital Management, LLC ($1.1M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Quoin Pharmaceuticals LT-ADR
- CUSIP
- 74907L409
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 14 | $12.1M |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 841,336 shares bought, net +841,336 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Ikarian Capital, LLC | 0.40% | New | 211,538 | $3.1M |
| Woodline Partners LP | 0.00% | New | 79,582 | $1.1M |
| Stonepine Capital Management, LLC | 0.89% | New | 78,189 | $1.1M |
| Aberdeen Group plc | 0.00% | New | 75,000 | $1.1M |
| Millennium Management | 0.00% | New | 74,817 | $1.1M |
| SummitTX Capital, L.P. | 0.03% | New | 64,795 | $935K |
| Boothbay Fund Management, LLC | 0.02% | New | 59,838 | $863K |
| ADAR1 Capital Management, LLC | 0.06% | New | 58,230 | $840K |
| AIGH Capital Management LLC | 0.21% | New | 49,323 | $712K |
| Resolute Capital Asset Partners LLC | 0.21% | New | 30,000 | $433K |
| Soleus Capital Management, L.P. | 0.02% | New | 25,000 | $361K |
| Simplify Asset Management Inc. | 0.00% | New | 17,448 | $252K |
| Centiva Capital, LP | 0.01% | New | 12,053 | $174K |
| Morgan Stanley | 0.00% | New | 3,000 | $43K |
| GAMMA Investing LLC | 0.00% | Add +649.6% | 2,084 | $30K |
| Rhumbline Advisers | 0.00% | Add +37.7% | 1,666 | $24K |
| SBI Securities Co., Ltd. | 0.00% | Add +12250.0% | 247 | $4K |
| UBS Group AG | 0.00% | Add +1600.0% | 17 | $245 |
"% of holder's portfolio" is QNRX's weight in each manager's 13F, not the share of Quoin Pharmaceuticals LT-ADR the manager owns.